4//SEC Filing
NEW RIVER PHARMACEUTICALS INC 4
Accession 0001140361-07-002094
CIK 0001288379operating
Filed
Jan 30, 7:00 PM ET
Accepted
Jan 31, 12:47 PM ET
Size
6.1 KB
Accession
0001140361-07-002094
Insider Transaction Report
Form 4
KIRK RANDAL J
DirectorChairman, President and CEO10% Owner
Transactions
- Award
Stock Appreciation Right
2007-01-25+298,200→ 298,200 totalExercise: $56.39Exp: 2017-01-24→ Common Stock (298,200 underlying)
Footnotes (2)
- [F1]All of these SARs are payable in cash.
- [F2]Vests in three equal annual installments beginning on January 25, 2008, but at all times the exercise of such SARs will be subject to the satisfaction by the Issuer of a liquidity formula as a condition to exercise of the SARs. The vesting of these SARs will accelerate in the event of a change in control of the Issuer.
Documents
Issuer
NEW RIVER PHARMACEUTICALS INC
CIK 0001288379
Entity typeoperating
IncorporatedVA
Related Parties
1- filerCIK 0001288379
Filing Metadata
- Form type
- 4
- Filed
- Jan 30, 7:00 PM ET
- Accepted
- Jan 31, 12:47 PM ET
- Size
- 6.1 KB